Delivery Order SPE2DB24D1021-SPE2DB25FESEH

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $10,523.47, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of December 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA). The $26,599.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,862.89 and a completion date of October 21, 2024. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET in a quantity of 30s. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price of $8,978.64 and an ultimate completion date of August 22, 2024. The contract is a delivery order and was awarded on August 21, 2024. It is not designated as a set-aside...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $10,098.75 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 5, 2025 with a completion date of June 6, 2025. The award is not associated with any set-aside designation, indicating open competition. As a significant vendor for the DLA,...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $4,644.48 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 24, 2025 with a completion date of March 25, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET prescription medication, with a ceiling value of $21,050.68. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of September 10, 2024 and was awarded on...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (SPE2DB20D1109|SPE2DB24FN80M) to the Defense Logistics Agency (DLA), a defense agency. The $17,592.35 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 14, 2024, with a completion date of March 15, 2024. The contract is a delivery order and has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s, with a ceiling value of $43,827.35. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $54,623.55 and is a firm fixed price delivery order, with an ultimate completion date of June 27, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and was awarded on June 26,...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESEH
    Delivery Order

This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (medical product) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 for a ceiling value of $21,341.64. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 25, 2024.

The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of federal contract awards, particularly with the DLA, to supply a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This specific award is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical.

Generated 5/20/25, 1:50 PM